The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular ...
Microbot Medical (Nasdaq:MBOT) announced today that it entered into agreements to sell common stock for proceeds of about $13 ...
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback